Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningGraft vs Host DiseasePeripheral Blood Stem Cell TransplantationStem CellsMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMelphalanBone Marrow TransplantationCombined Modality TherapyTreatment OutcomeRemission InductionHematologic NeoplasmsRecurrenceDisease-Free SurvivalSalvage TherapyMyeloablative AgonistsBusulfanGraft SurvivalSurvival RateCyclophosphamideTissue DonorsWhole-Body IrradiationSurvival AnalysisHematopoietic Stem CellsHodgkin DiseaseEtoposideHematopoietic Stem Cell MobilizationCytarabineLymphoma, Non-HodgkinRetrospective StudiesTransplantation ChimeraCarmustineGraft vs Tumor EffectHistocompatibility TestingVincristineLeukemia, Myeloid, AcuteThiotepaBone Marrow PurgingTime FactorsLeukemiaPrognosisLymphoma, Mantle-CellGranulocyte Colony-Stimulating FactorFollow-Up StudiesAntigens, CD34Embryonic Stem CellsAmyloidosisGraft vs Leukemia EffectAntibodies, Monoclonal, Murine-DerivedDoxorubicinMesenchymal Stem Cell TransplantationImmunosuppressive AgentsNeoplasm, ResidualAntineoplastic AgentsLymphoma, FollicularBoronic AcidsDexamethasoneAdult Stem CellsPyrazinesVidarabineAntineoplastic Agents, AlkylatingKidney TransplantationMyelodysplastic SyndromesThalidomideCord Blood Stem Cell TransplantationLymphomaLymphoma, T-Cell, PeripheralAutograftsLiver TransplantationLeukapheresisIfosfamideHistocompatibilityInduction ChemotherapyPluripotent Stem CellsCell DifferentiationT-LymphocytesPrednisoneCytomegalovirus InfectionsPodophyllotoxinCell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft RejectionAcute DiseaseLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMesenchymal Stromal CellsLymphoma, Large B-Cell, DiffuseStem Cell NicheLeukemia, MyeloidMaintenance ChemotherapyProspective StudiesLymphocyte TransfusionTransplantation ImmunologyLymphocyte DepletionSiblingsNeural Stem CellsAntibodies, Monoclonal